Clinical Trial Update: Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update covers a study evaluating metastasis-directed stereotactic body radiotherapy for oligometastatic, hormone-sensitive prostate cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Karin Soderkvist | Conditions: Prostate Cancer Metastatic, Radiation Therapy | NA | Status: RECRUITING